Mesoblast (MESO) Cash from Investing Activities Growth (3y) (2019 - 2023)
Mesoblast (MESO) Cash from Investing Activities Growth (3y) (2019 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -29.84% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 38.24% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -22.09% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Mesoblast | 18.89 Bn | 18.76 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 26.17% |
| Mar 31, 2023 | 26.80% |
| Dec 31, 2022 | 58.00% |
| Sep 30, 2022 | 7.08% |
| Jun 30, 2022 | 61.09% |
| Mar 31, 2022 | 14.63% |
| Dec 31, 2021 | 25.65% |
| Sep 30, 2021 | -36.41% |
| Jun 30, 2021 | 20.03% |
| Mar 31, 2021 | -193.56% |
| Dec 31, 2020 | -96.07% |
| Sep 30, 2020 | 49.42% |
| Jun 30, 2020 | -676.95% |
| Mar 31, 2020 | -53.43% |
| Dec 31, 2019 | -512.25% |
| Sep 30, 2019 | 4.45% |
| Jun 30, 2019 | -166.84% |
| Mar 31, 2019 | -10.34% |